Correlation Between Sumitomo Chemical and STRATEC Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sumitomo Chemical and STRATEC Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sumitomo Chemical and STRATEC Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sumitomo Chemical Co and STRATEC Biomedical AG, you can compare the effects of market volatilities on Sumitomo Chemical and STRATEC Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sumitomo Chemical with a short position of STRATEC Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sumitomo Chemical and STRATEC Biomedical.

Diversification Opportunities for Sumitomo Chemical and STRATEC Biomedical

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Sumitomo and STRATEC is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Sumitomo Chemical Co and STRATEC Biomedical AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on STRATEC Biomedical and Sumitomo Chemical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sumitomo Chemical Co are associated (or correlated) with STRATEC Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of STRATEC Biomedical has no effect on the direction of Sumitomo Chemical i.e., Sumitomo Chemical and STRATEC Biomedical go up and down completely randomly.

Pair Corralation between Sumitomo Chemical and STRATEC Biomedical

If you would invest  7,296  in STRATEC Biomedical AG on September 6, 2025 and sell it today you would earn a total of  0.00  from holding STRATEC Biomedical AG or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy98.44%
ValuesDaily Returns

Sumitomo Chemical Co  vs.  STRATEC Biomedical AG

 Performance 
       Timeline  
Sumitomo Chemical 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Sumitomo Chemical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's primary indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
STRATEC Biomedical 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days STRATEC Biomedical AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, STRATEC Biomedical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Sumitomo Chemical and STRATEC Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sumitomo Chemical and STRATEC Biomedical

The main advantage of trading using opposite Sumitomo Chemical and STRATEC Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sumitomo Chemical position performs unexpectedly, STRATEC Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in STRATEC Biomedical will offset losses from the drop in STRATEC Biomedical's long position.
The idea behind Sumitomo Chemical Co and STRATEC Biomedical AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.